Celsius Therapeutics Adds Greg Ryslik and Michael Boretti to C-Suite

Greg Ryslik has been appointed chief data officer of Celsius Therapeutics. He joins the Cambridge, MA-based company from Mindstrong Health, where he was vice president of data science. His experience also includes posts at electric carmakers Faraday Future and Tesla (NASDAQ: [[ticker:TSLA]]). In other moves, Celsius appointed Michael Boretti, formerly vice president of business development at Epizyme (NASDAQ: [[ticker:EPZM]]), to serve as chief business officer. Celsius raised $65 million last year to support its research developing drugs based on single-cell genomics.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.